<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amber Litzroth</style></author><author><style face="normal" font="default" size="100%">Vanessa Suin</style></author><author><style face="normal" font="default" size="100%">Chloé Wyndham-Thomas</style></author><author><style face="normal" font="default" size="100%">Sophie Quoilin</style></author><author><style face="normal" font="default" size="100%">Gaetan Muyldermans</style></author><author><style face="normal" font="default" size="100%">Thomas Vanwolleghem</style></author><author><style face="normal" font="default" size="100%">Kabamba-Mukadi, Benoît</style></author><author><style face="normal" font="default" size="100%">Vera Verburgh</style></author><author><style face="normal" font="default" size="100%">Marjorie Jacques</style></author><author><style face="normal" font="default" size="100%">Steven Van Gucht</style></author><author><style face="normal" font="default" size="100%">Veronik Hutse</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Public Health</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Jan-12-2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">19</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">1</style></issue></record></records></xml>